Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
about
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targetsStatins in paroxysmal atrial fibrillation: Beneficial to prevent recurrence but insufficient to stop progression to prevent recurrence but insufficient to stop progression.Drug-Induced Tendon Disorders.
P2860
Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Statin therapy lowers the risk ...... with end-stage renal disease.
@en
type
label
Statin therapy lowers the risk ...... with end-stage renal disease.
@en
prefLabel
Statin therapy lowers the risk ...... with end-stage renal disease.
@en
P50
P1476
Statin therapy lowers the risk ...... with end-stage renal disease.
@en
P2093
Jiunn-Lee Lin
Li-Ting Ho
P304
P356
10.1016/J.IJCARD.2015.01.040
P407
P50
P577
2015-01-26T00:00:00Z